Cargando…
The Role of m6A Epigenetic Modification in the Treatment of Colorectal Cancer Immune Checkpoint Inhibitors
Tumor immunotherapy, one of the efficient therapies in cancers, has been called to the scientific community’s increasing attention lately. Among them, immune checkpoint inhibitors, providing entirely new modalities to treat cancer by leveraging the patient’s immune system. They are first-line treatm...
Autores principales: | Tong, Huan, Wei, He, Smith, Alhaji Osman, Huang, Juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771774/ https://www.ncbi.nlm.nih.gov/pubmed/35069586 http://dx.doi.org/10.3389/fimmu.2021.802049 |
Ejemplares similares
-
Role of Epigenetic Modifications in Inhibitory Immune Checkpoints in Cancer Development and Progression
por: Saleh, Reem, et al.
Publicado: (2020) -
Epigenetic modification-related mechanisms of hepatocellular carcinoma resistance to immune checkpoint inhibition
por: Tao, Shengwei, et al.
Publicado: (2023) -
Epigenetic-related gene mutations serve as potential biomarkers for immune checkpoint inhibitors in microsatellite-stable colorectal cancer
por: Liu, Chao, et al.
Publicado: (2022) -
Ophthalmic immune-related adverse events associated with immune checkpoint inhibitors
por: Gan, Linyang, et al.
Publicado: (2023) -
The Pathogenic Role of Dysregulated Epigenetic Modifications in Autoimmune Diseases
por: Wu, Haijing, et al.
Publicado: (2019)